Wei Zexi, a 21-year-old college student who died last month of a rare form of cancer, had undergone a clinically uNPRoven treatment at a military hospital in Beijing.
The treatment cost Wei's family around 200,000 yuan and was unsuccessful. He died on April 12.
Before his death, Wei expressed anger at the hospital and search engine Baidu in an online post, accusing them of falsely claiming a high success rate for the treatment.
The treatment was a joint project between the hospital and a Shanghai-based private bio-tech company
The
